International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma-Reference-Cited by-同舟云学术

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma

Published:2022-10-27 Issue:3 Volume:108 Page:882-888
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Khwaja Jahanzaib,Kirkwood Amy A.,Isbell Lisa K.,Steffanoni Sara,Goradia Harshita,Pospiech Lisa,Fail Thomas,Nicholson Emma,Fletcher Kate,Linton Kim M.,Parsons Katrina E.,Elmusharaf Nagah,Eccersley Lydia,Eyre Toby A.,Chaganti Sridhar,Smith Jeffrey,Thakrar Nisha,Kutilina Alexandra,Calimeri Teresa,Martinez-Calle Nicolas,El-Sharkawi Dima,Osborne Wendy,Illerhaus Gerald,Fox Christopher P.,Ferreri Andrés J.M.,Schorb Elisabeth,Cwynarski Kate

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference13 articles.

1. Hollender A, Kvaloy S, Lote K, Nome O, Holte H. Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis. Eur J Cancer. 2000; 36(14):1762-1768.

2. Alvarnas JC, Negrin RS, Horning SJ. High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 2000; 6(3a):352-358.

3. Kasamon YL, Jones RJ, Piantadosi S. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Biol Blood Marrow Transplant. 2005; 11(2):93-100.

4. Akin S, Hosing C, Khouri IF. Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement. Blood Adv. 2022; 6(7):2267-2274.

5. Ferreri AJM, Doorduijn JK, Re A. MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. Lancet Haematol. 2021; 8(2):e110-e121.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration;Leukemia;2024-08-16

2. Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma;Leukemia;2024-05-15

3. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma;European Journal of Cancer;2024-01

4. Evidence-based management of primary and secondary CNS lymphoma;Seminars in Hematology;2023-12

5. How I treat secondary CNS involvement by aggressive lymphomas;Blood;2023-11-23